baber/WOPTO huggingface dataset:
Patent EP-0839353-B1 (EP)
Inventor: FALLS PATRICK T
IPC: G06F17/30
Filed: 1996-07-18
Granted: 2001-09-26
Abstract: A method and apparatus are disclosed for synchronizing transactions in a disconnectable network. Each transaction includes operations that were performed on a database replica on one computer while that computer was disconnected from another computer and hence from that other computer's replica. Transaction synchronization, which occurs after the computers are reconnected, transfers information from each computer to the other computer and applies updates to both replicas as appropriate. Transaction logs and clash handling tools may be used with the invention.
Patent EP-0858330-B1 (EP)
Inventor: YANNI JOHN M
IPC: A61K31/16
Filed: 1996-08-19
Granted: 2000-12-13
Abstract: Compositions containing a HETE derivative and methods of use for treating dry eye are disclosed.
Patent EP-0852793-B1 (EP)
Inventor: CARME CHRISTIAN
IPC: G10K11/178
Filed: 1996-09-27
Granted: 2001-11-28
Abstract: A filtering device consisting of a nonadaptive feedback filter that generates active attenuation of the vibration on the framework, without generating instability in a first frequency band, and an adaptive feedforward filter is disclosed. Feedforward filtering coefficients are adapted in real time according to an algorithm chosen to minimize the energy of the types of vibration which are picked up by a sensing device as a function of the energy of the types of vibration which are picked up by the sensing device, and of the previously measured transfer function, in the presence of a feedback filtering device and in the absence of a feedforward filtering device, between an actuator device and a first sensing device. The device makes it possible to linearize the feedback attenuation throughout a second frequency band which is wider than the first frequency band, to accelerate the convergence of the minimization algorithm and to enhance the robustness of the feedforward filter.
Patent EP-0811412-B1 (EP)
Inventor: TANAKA JUN
IPC: A61M1/02
Filed: 1996-12-26
Granted: 2003-07-30
Abstract: A leukocyte-removing filter material which consists of a porous element having fine pores of an average pore diameter of not less than 1.0  mu m but less than 100  mu m and a fiber structure composed of a plurality of fibers having an average fiber diameter of not less than 0.01  mu m but less than 1.0  mu m kept on the above porous element, wherein the porosity of the above filter material is not less than 50% but less than 95%, the proportion of the above fiber structure to the above filter material is not less than 0.01% by weight but less than 30% by weight, the ratio between the average pore diameter of the above porous element and the average fiber diameter of the above fiber structure is not less than 2 but less than 2,000 and the above fiber structure forms a reticulate structure; a process for producing the same; and an apparatus for removing leukocyte using the above filter material. <IMAGE>
Patent EP-0807791-B1 (EP)
Inventor: BAUER GERHARD
IPC: F24D19/06
Filed: 1997-02-08
Granted: 2003-06-11
Abstract: The breast part (12) under the window (13) contains a ventilator (14) with at least one inflow fan (15) connected to an air-suction opening on the outside of the room, and to an air-inlet opening (18) on the inside of the room. A heat exchanger (20) is positioned beneath the ventilator. The air inlet opening points towards the heat-exchanger. The ventilator on the room interior side has a facing (24) extending as far as over the heat exchanger and up to the top cover (22) of the ventilator, such as window sill. Air-flow over the heat exchanger is provided by a flow path and which can be blocked in its top part against the outflow of hot air rising by means of convection from the heat exchanger.
Patent EP-0922957-B1 (EP)
Inventor: VON GABAIN ALEXANDER
IPC: G01N33/569
Filed: 1997-12-05
Granted: 2000-03-29
Abstract: This invention is a method for determining the interaction of a target compound with a (poly)peptide of interest (which is selected from proteins, glycoproteins, or proteoglycans or sections thereof) exhibiting specific, prescribed properties. The interaction is characterized by at least one of the interactants being unknown. In general, only one of the interactants is unknown. When the unknown interactant is the (poly)peptide of interest, the method is based on three components: (1) a population of prokaryotic or eukaryotic cells displaying on their surface a combinatorial library in one protein, glycoprotein, or proteoglycan; (2) a target compound; and (3) a toxic agent. Interaction among the three components "imprints" the combinatorially varied polypeptide: that is, the interaction selects for those cells in which the combinatorially varied polypeptide interacts with the target compound in a prescribed manner. <IMAGE>
Patent EP-0799613-B1 (EP)
Inventor: WILDERBEEK ANTONIUS THEODORUS
IPC: A61K9/00
Filed: 1997-03-05
Granted: 2001-07-11
Abstract: The present invention relates to a vaccine container that contains one or more freeze-dried vaccine components. The vaccine component or components are present in two or more freeze-dried bodies, at least one of which is a lyosphere. Furthermore, the invention relates to methods for the preparation of such a vaccine container. Also, the invention relates to a vaccine pack, comprising the vaccine container.
Patent EP-0832891-B1 (EP)
Inventor: BELL MICHAEL GREGORY
IPC: A61K31/381
Filed: 1997-09-22
Granted: 2003-07-30
Abstract: The invention provides dihydrobenzoÄbÜindenothiophene compounds, intermediates, processes, formulations, and methods of inhibiting bone loss or bone resorption, particularly osteoporosis, cardiovascular-related pathological conditions including hyperlipidemia and related cardiovascular pathologies, and estrogen-dependent cancer.
Patent EP-0879028-B1 (EP)
Inventor: HAVEL MICHAEL
IPC: A61F2/00
Filed: 1997-02-06
Granted: 1999-10-27
Abstract: The invention concerns a vascular prosthesis assembly used in pathologically changed aortic sections with a transport container (1) as well as a radially-expandable prothesis (2) removable from this transport container (1). The prosthesis (2) is connected with traction elements (6), such as threads, while at the bottom (5) of the transport container (1) a feed wire (3) is applied nonpositively in the traction and compressing direction.
Patent EP-0934626-B1 (EP)
Inventor: DE JONG PAULUS CORNELIS
IPC: H03F3/45
Filed: 1997-03-24
Granted: 2000-05-24
Abstract: PCT No. PCT/NL97/00148 Sec. 371 Date Dec. 10, 1998 Sec. 102(e) Date Dec. 10, 1998 PCT Filed Mar. 24, 1997 PCT Pub. No. WO97/36371 PCT Pub. Date Oct. 2, 1997An instrumentation amplifier for absolute voltage amplification having a balanced voltage inlet and a balanced voltage outlet. The voltage inlet is coupled to first amplification units having a very high open-loop gain, and which is further coupled with a feedback network provided between the outputs and second inputs of the amplification units.
Patent EP-0929766-B1 (EP)
Inventor: SPRINGMANN STEFAN
IPC: H02G11/00
Filed: 1997-10-14
Granted: 2003-01-02
Abstract: A device for holding and guiding a cable assembly (11) between a first manipulator part (2) and a second manipulator part (3), which is movable in relation to the first part. The device comprises a cable assembly carrier (17) which is attached to the first manipulator part and which is elongated and tubular and that the cable assembly runs longitudinally through the cable assembly carrier. From an initial position, the movement of the cable assembly is influenced by a returning force.
Patent EP-0906088-B1 (EP)
Inventor: BYRA ANNA R
IPC: A61K31/45
Filed: 1997-05-14
Granted: 2005-11-23
Abstract: A second generation of antineoplaston therapies with markedly improved antineoplastic activity is disclosed. Among others, members of the antineoplaston family include phenylacetate (PN), 3-phenylacetyl-amino-2, 6, piperidinedione (CN), and hydrolysis derivatives of CN: phenylacetylglutamine (PG) and isophenylacetylglutamine (Iso-PG). In part, these increases in antineoplastic activity result from large increases in the transport of antineoplaston compositions into cells. Importantly and unexpectedly these increases in antineoplastic activity also result from the capacity of the drug delivery system to direct antineoplaston compounds intracellular trafficking to intracellular binding sites influencing cell viability and proliferation. Liposomal formulations of antineoplaston compositions increase in vitro antineoplastic activity by a factor of 750 to 1500 as compared to administration of antineoplaston compounds given without liposomal formulations. In addition, these liposomal formulations enhanced cellular uptake of antineoplaston compounds from 30 to more that 80 fold. Liposomal formulations were also found to increase intracellular levels of the antineoplaston CN (3-phenylacetyl-amino-2,6, piperidinedione) by directing CN to intracellular binding sites that influence cell viability and proliferation and block its hydrolysis. Under conditions where free CN has no antineoplastic activity, liposomally formulated CN can produce essentially complete and relatively long-lasting blockade of cell growth. Cell growth was found to be restored as intracellular levels of bound CN decrease to undetectable levels.
Patent EP-0914685-B1 (EP)
Inventor: STRASSER KARL
IPC: H01M8/04
Filed: 1997-05-28
Granted: 2002-07-24
Abstract: A process for operating a PEM fuel cell installation includes providing at least one PEM fuel cell module having an inlet valve for hydrogen H2 and an inlet valve for oxygen O2. In order to switch off the PEM fuel cell module, the oxygen O2 inlet valve is closed in a first step, and the hydrogen H2 inlet valve is closed in a second step when a predetermined oxygen O2 partial pressure at a cathode part of the PEM fuel cell module is reached. Reliable operation of the PEM fuel cell installation is guaranteed by this measure.
Patent EP-0912156-B1 (EP)
Inventor: MARTI VERNON PETER JOHN
IPC: C08L83/04
Filed: 1997-06-05
Granted: 2001-08-29
Abstract: A method of cooling skin comprising conveying a propellant composition to the skin as an aerosol, depositing the propellant on the skin and slowly volatilising the propellant to create a skin cooling sensation.
Patent EP-0915869-B1 (EP)
Inventor: COOPER ALAN B
IPC: A61K31/535
Filed: 1997-07-29
Granted: 2003-05-14
Abstract: Novel tricyclic N-cyanoimine compounds and pharmaceutical compositions are disclosed which are inhibitors of the enzyme, farnesyl-protein transferase. Also disclosed is a method of inhibiting Ras function and therefore inhibiting the abnormal growth of cells. The method comprises administering the novel tricyclic N-cyanoimines compound to a biological system. In particular, the method inhibits the abnormal growth of cells in mammals such as a human.
Patent EP-0920522-B1 (EP)
Inventor: NELSON EDWARD L
IPC: C12N15/85
Filed: 1997-08-14
Granted: 2003-10-29
Abstract: The invention is a "humanized" polynucleotide vector vaccine which uses covalent closed circular plasmid DNA, "naked DNA", to express target antigens. The vector is non-replicating in mammalian cells but is capable of extended stable expression of the target sequences in skeletal muscle and professional antigen presenting cells generating an immune response to the target antigen in immunized individuals. The polynucleotide vector is particularly useful in accommodating monomorphic and polymorphic nucleic acid sequences encoding tumor antigens via PCR technology.
Patent EP-1009310-B1 (EP)
Inventor: MAGRINI ANNA
IPC: A61B17/80
Filed: 1997-09-01
Granted: 2003-07-30
Abstract: The invention concerns a process for the production of osteosynthesis plates with a varying thickness to whatever degree. The plates are manufactured by a metal cutting process carried out on a composite structure made by a layer of the material which will form the osteosynthesis plate, bound through a layer of adhesive to a supporting layer with high thermal conductivity and mechanical strength. When the cutting process terminates, the osteosynthesis plate is separated from the supporting layer by heating the composite structure until the adhesive melts or by using a thinner suitable for the adopted adhesive.
Patent EP-0881969-B1 (EP)
Inventor: OJANEN LASSI MAUNO
IPC: B60J1/08
Filed: 1997-10-15
Granted: 2001-09-26
Abstract: A window unit configured to be removably mounted in an operative position in a motor vehicle having a half door and a soft roof structure disposed above the half door. The window unit comprises a rigid, transparent window panel and a surrounding frame of flexible material. A lower portion of the surrounding frame is configured to be releasably attached to an upper portion of the half door of the motor vehicle. An upper portion of the surrounding frame is configured to be releasably attached to a side edge of the soft roof structure of the motor vehicle. A window frame is mounted within a window-receiving opening formed through the surrounding frame. The window frame has a window track provided therein. The window panel is mounted within the window frame and has an outer peripheral edge thereof received in the window track. The surrounding frame has an inner portion extending around the window-receiving opening. The inner portion is devoid of openings. The window frame engages the inner portion of the surrounding frame in a clamped relationship such that clamping forces are applied to opposing surfaces of the inner portion to thereby securely mount the window frame and the window-panel within the window-receiving opening of the surrounding frame solely by virtue of the aforesaid clamped relationship without forming openings through the inner portion.
Patent EP-0946482-B1 (EP)
Inventor: METIVIER PASCAL
IPC: C07C45/65
Filed: 1997-11-19
Granted: 2002-07-24
Abstract: The present invention concerns a process for the preparation of a 4-hydroxybenzaldehyde and its derivatives. More particularly, the invention concerns the preparation of 3-methoxy-4-hydroxybenzaldehyde and 3-ethoxy-4-hydroxybenzaldehyde, respectively known as vanillin and ethylvanillin. The process for the preparation of a 4-hydroxybenzaldehyde and its derivatives is characterized in that it consists of selectively oxidising, to a carboxy group, the group in the 2 position with respect to the hydroxyl group, present in the phenolic compounds in a mixture comprising at least a phenolic compound (A) carrying formyl and/or hydroxymethyl groups in the 2 and 4 position, a phenolic compound (B) carrying a formyl or hydroxymethyl group in the 4 position, a phenolic compound (C) carrying a formyl or hydroxymethyl group in the 2 position, resulting in a mixture comprising a 3-carboxy-4-hydroxybenzaldehyde, a 4-hydroxybenzaldehyde and a 2-hydroxybenzoic acid, which then undergoes a decarboxylation operation to produce the 4-hydroxybenzaldehyde and a phenol which can optionally be recycled.
Patent EP-0856693-B1 (EP)
Inventor: PAWELZIK MANFRED
IPC: F16K47/02
Filed: 1998-01-15
Granted: 2001-09-19
Abstract: The washer (4) has at least one circle-section-shaped inlet (41) for cold and hot water. A plate cam (3) movably positioned in relative to the fixed washer has at least one overflow opening (30) and has a covering disc on its end side facing away from the fixed washer in the form of an overflow duct. The control edge (31) on the opening (30) and co-operating with the inlets in the fixed disc is toothed to reduce the noise of water flowing. The control edge is formed of a circle arc of at least 180 degrees with a radius smaller than the radius of the inner edge of the inlets (41). The teeth (35) become shorter the wider they are apart on both sides of the axis of symmetry (300).
Patent EP-0876081-B1 (EP)
Inventor: DERLINK MARKO
IPC: H05B1/02
Filed: 1998-04-16
Granted: 2004-10-27
Abstract: A tubular heating body, with an incorporated overheating safety system, has an outer connection bolt (8) with a diameter which is smaller than the diameter of the overheating safety unit (7). A shrouding (11), with electrical insulation, fits tightly at the wall of the overheating safety unit (7) and partly round the outer connection bolt (8). The interior of the mantle tube is filled with an electrical insulation casting mass (12) between the two sleeves (5, 9) and round the safety unit (7), the outer connection bolt (8) and the insulation shrouding (11). The mass (12) is a mixture of "Araldite" (RTM; epoxy resin) and corundum dust.
Patent EP-0887874-B1 (EP)
Inventor: APPEL WOLFGANG DR
IPC: H01M10/0569
Filed: 1998-06-10
Granted: 2010-09-22
Abstract: An electrolyte system for safer lithium batteries, with conductive lithium salt(s) and electrolyte liquid(s) containing partly fluorinated carbamate(s) of formula: (R<1>)(R<2>)N-C(=O)OR<3> (I), (in which R<1>, R<2> = linear 1-6 carbon (C) alkyl, branched 3-6C alkyl or 3-7C cycloalkyl; or R<1> and R<2> may be combined directly or with N and/or O to form a 3- to 7-membered ring which may also contain additional N atoms saturated with 1-3C alkyl, and in which the ring carbons may also carry 1-3C alkyl groups; one or more hydrogens in R<1> and R<2> may also be replaced by fluorine atoms; R<3> = partly- or per-fluorinated linear 1-6C alkyl or branched 3-6C alkyl, or partly fluorinated 3-7C cycloalkyl (optionally substituted with 1 or more 1-6C alkyl groups)). Also claimed are: (i) secondary lithium batteries with a greater level of safety containing the electrolyte system; and (ii) a method for increasing the safety of such batteries by using this system as the electrolyte.
Patent EP-0924369-B1 (EP)
Inventor: HOFFMANN OTTO
IPC: G07C9/00
Filed: 1998-11-26
Granted: 2000-08-16
Abstract: A door mounting for a closure mechanism of a door (2), wherein the door mounting exhibits a locking means (11), which locking means (11) blocks a locking mechanism (29, 36) in a locking position, wherein the locking mechanism (20, 36) is mechanically coupled to the closure mechanism (2) and thus an actuation of the closure mechanism is not possible, if the locking means (11) is disposed in the locking position. The locking means (11) can be moved into an unlocked position with the aid of an adjustment mechanism (10, 50), wherein a support mechanism (15, 16) retains the locking means (11) in the region of the unlocked position and releases an actuation of the closure mechanism of the door (2).
Patent EP-0879917-B1 (EP)
Inventor: OWEN DAVID WILLIAM
IPC: D21H21/16
Filed: 1998-05-19
Granted: 2004-09-01
Abstract: The suitability of paper for printing by so-called "colour digital presses" of the kind which use a liquid toner or ink is enhanced by the use of a treatment composition comprising an aluminate salt or a salt of a weak acid and a strong base in an amount such as to impart an alkaline surface pH value to the paper. The treatment composition preferably also contains starch or another surface agent, so that the treatment composition also functions as a surface sizing composition.
Patent EP-0968674-B1 (EP)
Inventor: BELOT GERARD
IPC: A47B88/04
Filed: 1998-07-03
Granted: 2006-01-11
Abstract: The display stand is made from sheets of card that are cut and folded. Extruded sections (60) are engaged on the walls of the card, to hold two parts (2A,2B) together. They have two parallel legs (6A,6B) that are joined at the centre (13) to form a slot (70) that engages on the card. The end of one leg (6A) has a hook (15), inside the slot, that engages in a complementary hollow in the card. The extruded sections can form slides for a drawer or are used to lock sheets of card together.
Patent EP-0926775-B1 (EP)
Inventor: PINI LEONARDO
IPC: H01R13/516
Filed: 1998-12-11
Granted: 2003-03-19
Abstract: The orthogonally mounted plate has access for the incoming cable, holding the cable in position. The inner section slides into an outer box.
Patent EP-1015460-B1 (EP)
Inventor: BARANSKI JOHN J
IPC: C10M139/00
Filed: 1998-01-23
Granted: 2002-11-27
Abstract: A composition of matter having the structure   <IMAGE>   wherein R1, R2, R4, and R5 are independently a member selected from the group consisting of alkyl, cycloalkyl, aryl, aralkyl, and alkaryl, and R3 is alkylene. Lubricants and lubricant additives comprising the composition are also disclosed. The lubricants are preferably lubricating oils.
Patent EP-1021246-B1 (EP)
Inventor: DEBE MARK K
IPC: H01M4/86
Filed: 1998-04-29
Granted: 2004-06-30
Abstract: Nanostructured elements are provided for use in the electrode of a membrane electrode assembly for use in fuel cells, sensors, electrochemical cells, and the like. The nanostructured elements comprise acicular microstructured support whiskers bearing acicular nanoscopic catalyst particles which may comprise alternating layers of catalyst materials, which may comprise a surface layer that differs in composition from the bulk composition of the catalyst particles, and which may demonstrate improved carbon monoxide tolerance.
Patent EP-0998316-B1 (EP)
Inventor: KIRCHHOFER FRITZ
IPC: A61M5/315
Filed: 1998-07-17
Granted: 2004-11-03
Abstract: The present invention relates to a system for locking a dosing button in a device for the administration of a product to be injected in predetermined doses. This device comprises a body (1) with a housing (2) for the product, wherein a selected dose for injection is transported from said body out of a container (3) through a transport member (4). This device also comprises a drive member (5,7) for the transport member (4) as well as a dosing button (9) coupled to the drive member (5, 7) which is mounted so as to be capable of sliding within the body (1). The button ensures the transport of the selected dose when it is displaced from a first position into a second by actuating the drive member (5, 7). The dose is selected in the first position by rotating the dosing button (9) so that is can be moved from a first rotation position indicating that no transport is possible into a second rotation position. This device further comprises a first indicator sleeve (15) affixed to the body as well as a second indicator sleeve (17) capable of rotation together with the dosing button (9), wherein both sleeves include indication members (16, 18) for reading the selected dose according to the rotation position of said sleeves (15, 17) relative to each other. This device also comprises an anti-sliding member (11, 12, 13) which allows the dosing button to be moved from the first position into the second only when the indicator sleeves (15, 17) are placed in a zero position relative to each other thus indicating a "zero" dose. The anti-sliding member (11, 12, 13) can be unlocked by depressing on a trigger button (14), wherein the second indicator sleeve (17) releases the trigger button (14) for external access only when both indicator sleeves (15, 17) are at the zero position.
Patent EP-0979137-B1 (EP)
Inventor: DORNSEIFFER JUERGEN
IPC: B01D53/88
Filed: 1998-04-25
Granted: 2003-04-16
Abstract: In an electrically heated catalytic converter including a heater consisting of a structure having an open porosity so as to permit fluid to flow therethrough, a heterogeneous catalyst is disposed within the heater structure. The heater structure, which includes the catalyst, is capable of accommodating sufficient electrical energy to provide the activation energy required for a particular catalytic reaction to be performed by the catalytic converter.